GCTK Glucotrack, Inc.


$ 5.62 $ -0.25 (-4.3 %)    

Thursday, 13-Nov-2025 17:13:48 EST
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 5.67
$ 5.86
$ 5.29 x 63
$ 6.47 x 600
$ 5.62 - $ 6.04
$ 4.22 - $ 468.00
9,540
na
5.16M
$ 3.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 glucotrack-q3-eps-464-up-from-109-thousand-yoy

GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(4.64) per share. This is a 99.58 percent increase over losses of $(1.09...

 glucotrack-has-been-granted-us-patent-number-12453494-titled-methods-and-systems-for-measuring-glucose-having-improved-decay-rates-and-lag-times

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12453494).pn

 reported-september-12-2025-glucotrack-issues-36m-unsecured-convertible-promissory-note-to-investor-for-a-purchase-price-of-3m

On September 12, 2025 (the "Issue Date"), Glucotrack, Inc. (the "Company") entered into a Note Purchase Agreeme...

Core News & Articles

SMCI: 6% | Supermicro Launches Global Delivery Of NVIDIA Blackwell Ultra AI Systems For Scalable, Turnkey Deployment GCTK: 190%...

 glucotrack-enters-purchase-agreement-with-sixth-borough-capital-sixth-borough-capital-fund-commits-to-purchase-up-to-20m-of-cos-common-stock

-SEC Filing

 glucotrack-q2-eps-962-up-from-98400-yoy

GlucoTrack (NASDAQ:GCTK) reported quarterly losses of $(9.62) per share. This is a 99.02 percent increase over losses of $(984....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION